Millennials: Should You Just Say No to Weed Stocks?

Millennials are advised to avoid weed stocks. CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST), Canopy Growth Corp (TSX:WEED)(NYSE:CGC), and the rest of the cannabis companies are dealing with issues that are affecting the industry as a whole.

| More on:
Cannabis stocks have fallen.

Weed stocks offer terrific growth potentials, yet millennials should think doubly hard before taking a position in Canada’s cannabis producers. If you’re inexperienced in the cannabis space, all the more reason to say no to weed stocks.

Aside from the lack of fundamentals (and profits), cannabis companies are giving the industry a bad image because of controversies and scandals. Canopy Growth (TSX:WEED)(NYSE:CGC) and CannTrust (TSX:TRST)(NYSE:CTST) are popular weed stocks. However, you shouldn’t risk your money on them.

Dangerous weed stock

CannTrust is not a trustworthy cannabis company. The company’s former chairman and CEO deliberately broke legal cannabis cultivation laws. CannTrust was cultivating cannabis from unlicensed cultivation rooms for six months and selling them to unsuspecting clients.

When Health Canada found out the anomaly through a random audit, CannTrust had no choice but to admit to the fraudulent operations. The expulsion and resignation of the CEO and chairman followed. The stock was trading as high as $10 in late April but has sunk to $2.20, or by 78%, as of this writing.

On August 1, 2019, the Ontario Securities Commission received an application from CannTrust for a management cease trade order. The investing public is free to trade the stock, but management, directors, and other insiders are prohibited.

The latest from the grapevine is that before the end of September, CannTrust will no longer be on the S&P/TSX Index. The company has lost its moral ascendancy. No one would dare to invest a weed stock that nearly brought the entire cannabis industry down.

The industry giant is high risk

The standing of Canopy Growth is not as grave as that of CannTrust. The largest cannabis company has no record of violating of cannabis regulations. However, the Canopy’s market value is down from $14 billion to $11 billion. The stock price was doing almost $70 in late April but is down by 55.53% to $33.23 today.

Canopy is posting losses at a torrid pace. The company’s founder and former CEO Bruce Linton was fired by the major partner and investor Constellation Brands. The American alcohol beverage giant did not like the excessive spending and mounting losses. Canopy lost more than $1 billion in the most recent quarter.

Unlike CannTrust, Canopy’s future is not bleak. In the next 12 months, analysts see the company’s revenue to increase by 290.9%. Its EBITDA in the same forecast, however, would be negative.

Despite being the cannabis industry’s giant, Canopy is not a profitable company. It would take a long time before business fundamentals improve. But Canopy will certainly achieve long-term sustainable growth.

“No buy” zone

Except for CannTrust, which is in dire straits, most of the weed stocks are in the same boat with Canopy Growth. Profits are as elusive as ever. There’s no way to tell when the industry will stabilize. At present, volatility is at an all-time high.

As mentioned earlier, the weak fundamentals, controversies, and scandals are sufficient reasons to declare the cannabis sector a “no buy” zone. Millennials, as well as baby boomers, should be smart enough to look for less-risky stocks that offer sure returns.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »